(CDllb), CR4 a-chain (CDllc), LPS-R related Ag (CD14), 3-FALlx-hapten (CD15), FcyRlll (CDl6), lactosylceramid (CDwl71, the B-cell antigen CD19, or CR1 (CD35). In situ expression of leukocyte antigens on CMC was demonstrable by indirect irnmunoperoxidase staining technique and double-labeling immunohistochemistry. Almost all CMC (90%) reacted with MoAbs against tryptase and chymase and thus were M&. Cardiac mast cells were also stained by the heparin-binding dye Berberine sulfate and expressed measurable amounts of histamine (4.6 f 1.4 pg per cell). Cross linking of either IgE receptor or SCF receptor (c-kit) on CMC resutted in histamine secretion (non-specific release: <6% of total histamine, algE induced 12% t o 52%; SCF-induced release: 9% t o 18%). whereas neither substance P (a skin MC agonist) nor the basophil agonist FMLP showed an effect on CMC. Together, the CMC is an M& primarily located in the appendage of the atrium. This novel type of MC exhibits surface membrane antigen and functional properties similar t o those of lung and uterus MC. FcERI on MC results in a cascade of signal transduction events culminating in mediator secretion.1 '-18.20 . 21 The MGF receptor (c-kit) has recently been clustered as CD1 17.22 Other well-defined cell surface membrane structures on human MC are the common p chain of p1 integrins (CD29), the alpha chain of the p1 integrin VLA-4 (CD49d), the ICAM-l antigen (CD54), the Pgp-l homing receptor (CDM), and leukosialin (CD43).19,'3-Zh Substantial evidence exists for mast cell heterogeneity in humans and mice. In mice two types of MC, mucosal mast cells (MMC) and connective tissue-type mast cells (CTMC), have been d e s~r i b e d .~~'~~ CTMC differ from MMC in their staining properties, mediator content, expression of proteoglycans, protease expression, and responses to secretagogues. In humans, mast cell heterogeneity has also been described. Human mast cell subtypes can be distinguished, based on the distribution and expression of proteolytic enzymes in various ~r g a n s "~"~ and response of MC to activating c~rnpounds."~'~ Thus, human skin MC are responsive to substance P (SP) and morphine, whereas MC isolated from lung, the gastrointestinal tract, or uterine tissue are Skin MC contain tryptase and chymase (MCTC),30-32 whereas MC in human lung or the gastrointestinal mucosa express tryptase but only low or undetectable amounts of chymase (T type of MC).
During the past few years, a number of studies have been performed to provide further evidence for organ-specific mast cell heterogeneity in man. In the course of these studies, extensive phenotypic and functional analyses have been performed on MC derived from lung,3s gastrointestinal and uterus.zs~z6~37 In this report, we present the histologic, immunophenotypic, biochemical, and functional characterization of the human cardiac mast cell.
THE HUMAN CARDIAC MAST CELL
uronidase, DNAse, substance P (SP), Ca-ionophore A23187, and FMLP were purchased from Sigma Chemical CO (St Louis, MO). Buffers were as follows: 1 L Ca/Mg free Tyrode's buffer contained 0.2 g KCI, 0.05 g NaHzP04H20, 0.8 g NaCl, and 1 g glucose. PIPES buffer (for histamine release) contained 25 mmoVL PIPES, 110 mmoVL NaCl, 5 mmoVL KCI, and 2.0 mmoVL CaClz (pH 7.35).
Recombinant human (rh) stem cell factor (rhSCF) was purchased from Genzyme (Cambridge, MA).
A number of MoAbs were used for the characterization of CMC. The following MoAbs were obtained from the IIIrd, IVth, or Vth International Workshops and Conferences on Human Leukocyte Differentiation Antigens (Oxford, UK, 1986; Vienna, Austria, 1989; Boston, MA, 1993"): T11 (CD2), MHM24 (CDlla), T5A7 95C3 (CD1 17), and 1D5.El1 (CD1 17). A number of MoAbs were purchased: anti-chymase MoAb and anti-tryptase MoAb from Chemicon (Temecula, CA); IOT-3 (CD3), ALB6 (CD9), K20 (CD29), 84H10 (CD54). SZ21 (CD61), and E-124-2-8Kk2 (anti-IgE) from Immunotech, (Marseille, France); 4B4 (CD29), MY-9 (CD33), and B4 (CD19) from Coulter (Hialeah, K); Leu-3a (CD4), Leu-l5 (CDllb), SHCL-3 (CDllc), Leu 22 (CD43). and Leu 44 (CD44) from Becton Dickinson (Sunnyvale, CA); Y2/51 (CD61), F8/86 [anti-von Willebrand factor (vWF)] from Dako (Glostrup, Denmark); BA-2 (CD9) from Jansen (Beerse, Belgium); BMA0111 (CD2), BMA010 (CD54), and 1.D9.3D6 (anti-c-kit) from Boehringer Mannheim (Mannheim, Germany); and 1.D5.Ell (anti-ckit) from Cedarlane (Hornby, Canada). A number of MoAbs were provided by 0. Majdic and W. Knapp (Institute of Immunology, University of Vienna, Vienna, Austria): VI"D5 (CD15), VIM-l2 (CDllb), VIM-l3 (CD14); and VIFcRIII (CD16). The anti-c-kit MoAb YB5.B838 was kindly provided by L.K. Ashman (University (CDwl7), F-10-44-2 (CD44). E l l (CD35), lA2.C5 (CDl17/~-kit),
3877
of Adelaide, Adelaide, Australia). The MoAbs used in this study are listed in Table 1 .
Isolation of CMC. Human CMC were isolated from atrial appendages by enzymatic digestion. Cardiac tissue was obtained from patients (n = 14) with cardiomyopathy (CMP, heart transplantation) after informed consent was given. The atrial appendages of the explanted hearts were resected after transplantation and placed into Ca/Mg-free Tyrodes' buffer. Thereafter, tissue was chopped into small pieces, and the fragments were washed extensively in Tyrodes' buffer. Then, tissue was incubated with collagenase (30 U/mL) for 2 hours at 37°C and the dispersed cells were recovered by filtration through Nytex cloth. After washing twice in 0.9% NaCI, the cell suspension was incubated with DNAse (0.5 mg/mL), hyaluronidase (0.5 mg/mL), and pronase-E (2 mglmL) for 15 minutes at 37°C to remove (myocyte) cell ghosts. Cells were washed three times in NaCl at room temperature. The percentage of MC was determined by toluidine blue or Giemsa staining. Isolated MC were cultured in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS), glutamine, and antibiotics at 37°C for at least 24 hours before being analyzed. In initial experiments, MC (n = 4) were isolated from various sites of the heart including the left and right ventricles, the atriums (left and right), and the septum. MC from uterus (uterus myomatosus patients, n = 5), foreskin (circumcision, n = 2). and lung (bronchiogenic carcinoma, n = 4) tissue were isolated (after informed consent was given by patients) by enzymatic digestion as described Combined toluidine blue/immunojlwrescence staining of isolated CMC. Expression of cell surface markers on CMC was analyzed by a combined immunofluorescence/toluidine blue staining technique as described p r e v i~u s l y ?~.~~ Briefly, cells were incubated with MoAbs for 30 minutes at 4°C and washed twice in phosphate-buffered saline Mac For personal use only. on November 11, 2017. by guest www.bloodjournal.org From 3878 SPERR ET AL (PBS). Cells were then conjugated with a second-step fluoresceinlabeled goat F(ab') IgG + IgM anti-mouse antibody (30 minutes at 4°C). Thereafter, cells were fixed in 0.025% glutaraldehyde solution for 1 minute. After three washes, the cells were incubated with toluidine blue (0.0125%) for 10 minutes at room temperature and again washed three times. The cell suspension was analyzed under a fluorescence microscope (Olympus, Vienna, Austria) by two independent observers.
In situ toluidine blue and Berberine surfate staining of CMC. Deparaffinated sections were stained with 1 % toludine blue in methanol (pH 7.4) for 5 minutes, washed, and then incubated with 0.1% acetic acid in methanol. Slides were then air dried and mounted.
Berberine sulfate staining was performed on deparaffinated sections after fixation in 70% ethanoV30% acetic acid for 15 minutes. Slides were then washed in ethanovwater and incubated in 0.02% Berberine sulfate (Serva, Heidelberg, Germany) with 1% citric acid (pH 4.0) for 20 minutes. Thereafter, slides were washed in water and citric acid (l%, pH 4.0), air dried, and mounted in Entallan (Merck, Darmstadt, Germany).
Determination of CMC numbers in tissue sections. The number of CMC in cardiac tissues was assessed on paraffin-embedded material stained with Giemsa or anti-tryptase MoAb (see below). To establish correlations between the numbers of Giemsa-stained cells, tryptase-positive cells, and chymase-positive cells, serial sections were examined. Stained sections (at least 5 X 5 mm) were scanned into a personal computer. Then, the cardiac areas (total myocardium, total endocardium) in a given section were marked, and the sizes of the areas were calculated by a computer program (Vistatips; AT& T, USA). The total numbers of CMC in each cardiac region were counted under light microscope at 4 0 0~ magnification by two independent observers. The numbers of CMC were calculated and expressed as cells per square millimeter.
In situ staining of CMC with MoAbs. For in situ evaluation of CMC, atrial tissue was obtained from four CMP patients. After resection the tissue was cut and fixed in neutral buffered formalin (8% formalin in 0.08 m o m sodium phosphate, pH 7.4) or in Carnoy's fluid (60% ethanol, 30% chloroform, 10% glacial acetic acid). In initial experiments both fixatives were used and gave almost the same results with slightly better visualization for Carnoy's fluid fixation (anti-tryptase and anti-chymase staining). In all subsequent experiments, formalin was used as fixative. Tissue was embedded in paraffin and cut into thin sections (2 pm) for immunohistochemistry. Immunohistochemistry of CMC was performed essentially as described by Hsu et and Irani et al. 32 Sections were dewaxed, and the endogenous peroxidase was blocked by 5% H202 in methanol for 15 minutes. After each step the tissue was rinsed twice in Trisbuffered saline (TBS) at pH 7.6. Slides were treated with TBS and 0.1% protease type XIV (Sigma, St. Louis, MO) for 10 minutes. Non-specific binding was blocked with TBS and 1% horse serum (Vector, Burlinghame, CA). Primary MoAbs (MoAbs and titres are listed in Table I ) were diluted in TBS, 1% horse serum and applied for 60 minutes. Sections were then incubated with a biotinylated horse-anti-mouse IgG (Vector) and streptavidin-biotin-peroxidase complexes (Dako) for 30 minutes. Diaminobenzidin (DAB; Vector) was used as chromogen, giving a brown reaction product with horseradish peroxidase. Sections were counterstained in Gill's hematoxylin. Control slides were similarly treated, either with the primary antibody omitted or using isotype-matched control MoAbs.
In situ double immunohistochemistry. Sequential and simultaneous double-labeling immunohistochemistry of CMC was performed essentially as described by bani et a1" for tissue MC. For sequential staining, sections were first incubated with primary MoAbs, then with secondary biotinylated horse-anti-mouse IgG, and thereafter with fluorescein isothiocyanate (FITC)-conjugated streptavidin (Vector). Thereafter, an alkaline phosphatase-conjugated antibody for the detection of the second antigen (tryptase) was applied. The reaction was visualized by fast blue salt and naphtol AS-MX phosphate resulting in a blue color. For simultaneous double-labeling of CMC, tissue sections were incubated with a mixture of a biotinylated antibody and an alkaline phosphatase-conjugated antibody. Cells reacting with alkaline phosphatase-conjugated antibody stained blue by addition of fast blue salt, and the reactivity of the biotinylated antibody was visualized by either FITC-streptavidin or peroxidaseconjugated streptavidin and DAB. Double-labeling control experiments were done with anti-vWF MoAb F8/86 and alkaline phosphatase-conjugated anti-tryptase. In these experiments, anti-vWF MoAb stained endothelial cells but not CMC, whereas anti-tryptase MoAb stained CMC but not any other cells. Coexpression of antigens in CMC was also assessed by use of serial sections (using tryptase MoAb as control).
Histamine release experiments. Histamine release was performed on CMC according to published techniques. 40 In the case of IgE-dependent release, CMC were preincubated with monoclonal IgE (10 pg/mL) for 3 hours, washed, and resuspended in PIPES buffer. CMC were then exposed to various concentrations of antiIgE MoAb E-124-2-8 (De2) (0.1-10 pg/mL) for 30 minutes. CMC were also exposed to Ca-ionophore A-23 187 (0.1-10 pg/mL), rhSCF/ MGF (0.001-1,OOO ng/mL), compound 48/80 (0.01-1,OOO pg/mL), SP (10-~-10-~ mom); or FMLP (10-2-10-6 mom). Cells were incubated with these stimuli in 96-well microtiter plates (Costar, Cambridge, MA) for 30 to 90 minutes at 37°C. The priming effect of rhSCF on IgE-dependent mediator release of CMC was also analyzed. For this purpose, CMC were first exposed to IgE (see above), then to rhSCF (10 ng/mL) versus control medium for 15 minutes at 37°C and then stimulated with various concentrations of anti-IgE (0.1-10 pg/mL) for 30 minutes. After centrifugation at 4"C, cellfree supernatants were recovered and analyzed for the presence of histamine. Total histamine was determined in cell lysates after freeze-thawing. Histamine release was calculated as percent of total histamine.
Measurement of histamine and tryptase by radioimmunoassay. Histamine was measured in cell lysates or supernatants by a commercial radioimmunoassay (Immunotech, Marseille, France) as described.* Tryptase was measured in cell lysates by radioimmunoassay as reported previo~sly.~' The tryptase assay showed a detection limit of 10 pg/mL, and no crossreactivity with histamine, heparin, TNF, or other interleukins or cytokines was found.
Statistical evaluation of data. Differences in mediator content and secretion as well as differences in the numbers of CMC in the various cardiac regions were analyzed by standard tests including the paired Student's t test. Results were considered significantly different when P < .05.
RESULTS
Isolation of mast cells. For the isolation of MC cardiac tissue was digested enzymatically using collagenase, hyaluronidase, DNAse, and pronase-E. In a first step of the study tissue, digests were prepared from the left and right ventricles, atrium, septum, and the atrial appendages. Interestingly, significant numbers of MC could be detected in suspensions prepared from the atrial appendages only. Atrial appendage suspensions contained 0.5% to 1.5% CMC as assessed by Giemsa or toluidine blue staining. In digests obtained from other heart regions (septum, ventricle), however, substantial amounts of CMC were not detected (<0.1% of cells). After removal of myocyte cell ghosts using DNAsdpronase-E and short-term (24 hours) culture, more than 90% of the isolated cells were viable by dye exclusion. Cardiac tissue treated with collagenase alone (but not DNAsdpronase-E) showed poor viability with many cell ghosts, and no MC could be For personal use only. on November 11, 2017. by guest www.bloodjournal.org From recovered. CMC were cultured in RPM1 1640 medium plus 10% FCS for at least 24 hours before being analyzed. Lung, skin, and uterus MC were isolated as Purity of isolated lung MC was 3% to 8%; skin MC, 7% to 12%; and uterus MC, 0.5% to 2.5%.
CMC cell sugace membrane phenotype and comparison with other mast cell types. A panel of MoAbs directed against well-established leukocyte differentiation antigens was used to characterize human CMC and to compare the phenotype of these CMC with the phenotype expressed by other mast cell types. CMC were found to react with MoAbs against surface IgE, the receptor for SCF (c-kit R, CD117), the p24 antigen (CD9), the Pgp-l homing receptor ( C M ) , the pan leukocyte antigen (CD45), and the ICA"1 antigen (CD54) ( Table 2) . CMC were not recognized by MoAbs to LFA-2 (CD2), the T-cell receptor (CD3), the class II receptor T4 (CD4), the alpha chain of the 8 2 integrin LFA-1 (CD1 la), the alpha chain of the 8 2 integrin Mac"23biR alpha chain (CD1 lb), p150/95/CR4 alpha chain (CD1 IC), the LPS receptor-related monocyte antigen CD14, the x-hapten/3-F& (CD15), the FcyIUII (CD16), lactosylceramid (CD17), the B-cell associated antigen CD19, and CRl (CD35). CMC, lung MC, skin MC, and uterus MC expressed an almost identical cell surface antigen profile. The phenotypes of human MC, of the human mast cell line HMC-1, and of human basophils are depicted in Table 2 .
In situ detection, localization, and distribution of CMC. In situ staining of CMC was performed by use of conventional dyes (toluidine blue, Giemsa, Berberine sulfate) as well as by immunohistochemistry using MoAbs. For evaluation of CMC numbers in cardiac regions, Giemsa-stained or anti-tryptase-stained slides were used. Indeed, all CMC expressed tryptase (Fig l) , and an excellent correlation between the number of Giemsa-positive and tryptase-positive cells in serial sections obtained from cardiac tissue was found (ratio tryptase-:Giemsa-stained cells, 0.9 to 1.1). Histologic examination confirmed the "accumulation" and relatively high numbers of CMC in the atrial appendages as compared with other heart regions (myocardium of atrial appendages, 2.16 2 0.7 MC/mmz v ventricle, 0.56 % 0.18 MC/mm2; P < .05). In the atrial appendages, CMC could be detected in the myocardium (2.16 2 0.7 MC/mm2 ; Fig l) , the endocardium (2.24 2 0.9 MC/rnm2), and the epicardium. CMC were often found in close apposition to or near small vessels and showed the typical morphology of MC with dense-packed granules and a mononuclear phenotype.
The calculated amount of CMC per gram of weight of atrial tissue ranged from 2.7 x lo4 to 3.1 x lo".
In situ detection of mast cell antigens on CMC by immunohistochemistry. In situ expression of leukocyte antigens on CMC was demonstrable by immunohistochemistry including double-staining techniques. Expression of CD antigens expressed on MC (CD9, CD29, CD43, CD44, CD54, CD61, and CD1 17) could be confirmed for CMC (Table 2) . Expression of the myeloid antigen CD33 (gp 67) and CD43 (leukosialin) on CMC was only demonstrable by immunohistochemistry as enzymatic treatment (pronase-E) was found to interfere with expression of these molecules on the cell surface of isolated CMC. Five different MoAbs against the MGF receptor (SCF receptor, c-kit, CD1 17) were found to For personal use only. on November 11, 2017. by guest www.bloodjournal.org From In situ double immunohistochemistry of CMC. Coexpression of tryptase and chymase in single CMC was demonstrable by simultaneous double immunohistochemistry in sections obtained from the epi-myocardium of the atrial appendage. Paraffin-embedded sections were exposed to a mixture of a biotinylated anti-chymase and an alkaline phosphatasezonjugated anti-tryptase antibody. CMC reacting with anti-tryptase MoAb were visualized using fast blue salt (A); the reactivity of the antichymase MoAb was visualized using flTC-streptavidin (B). Irrelevant isotype-matched control MoAbs showed no reaction with CMC.
For (Fig 1, Table 3 ) and thus were of the TC-type of MC. Coexpression of both enzymes in single cells was demonstrable by double immunohistochemistry (Fig 2) . Examinations of serial sections confirmed the coexpression of both enzymes in CMC and revealed a chymase:tryptase ratio of 0.8 to 1 .O. Thus, the predominant type of MC present in cardiac tissue is the MCTc type. No differences between endocardial, myocardial, or epicardial CMC in expression of cell surface markers or mast cell enzymes was found.
Biochemical characterization of CMC. Mast cell-related mediators (histamine, tryptase) in cardiac tissue suspensions were analyzed after short-term culture and freeze thawing of cells. The calculated cellular amount of histamine in CMC obtained from the atrial appendages was 4.6 5 1.4 pg per MC, and the calculated amount of tryptase was 2.7 2 0.4 pg per CMC. CMC in atrial appendages could also be stained by the heparin-binding dye berberine sulfate.
Activation of CMC by c-kit ligand and other mast cell agonists. The integrity and functional properties of the isolated atrial CMC were tested by histamine release experiments. Non-specific, spontaneous histamine secretion was always below 6%, indicating excellent viability. Crosslinking of the IgE receptor by IgE + anti-IgE (0.01 to 10 pgl mL) resulted in specific release of histamine from CMC (12% to 52% histamine release at optimal concentrations of anti-IgE, P < .01). Activation of CMC via the mast cell ckit receptor (CD117) by rhSCF (0.OOOl to 1,000 ng/mL) was also followed by specific (dose-dependent, nontoxic) mediator secretion (Fig 3) . Optimal concentrations of rhSCF produced 9% to 18% histamine release after an incubation time of 90 minutes (P < .01). The effects of rhSCF were time-dependent, and no significant effect of SCF was seen at 20 minutes of incubation (P > .05). Preincubation of CMC with rhSCF (10 ng/mL) followed by stimulation with anti-IgE resulted in enhancement of histamine release when compared with activation by anti-IgE alone (P < .05; Fig   4) . Calcium ionophore A-23187 also induced histamine secretion from CMC (36% to 62% histamine release at optimal concentrations). In contrast, SP as well as compound 48/80 (two skin mast cell agonists) and the basophil agonist FMLP were ineffective over the dose range tested (P > .05; Table   4 ).
In selected experiments, skin MC and CMC were exposed to SP to morn) after an identical isolation protocol, ie, exposure to a mixture of pronase E, collagenase, DNAse, and hyaluronidase. Again, SP induced histamine secretion in skin MC (15%), but failed to induce histamine release in CMC (<5%). observed, depending on the origin of MC and the tissue analyzed. We report on the isolation, distribution, and characterization of human CMC. The biochemical, immunophenotypic, and functional properties of this novel mast cell type suggest a close relationship to other mast cell types and provides further evidence that MC form a unique cell lineage within the hematopoietic system. Most interestingly, the CMC is an MCTC and primarily located in the appendage of the atrium.
MC express a unique profile of cell surface membrane antigens and can be distinguished from other hematopoietic cells by their immunophenotype. '9.23 In this investigation expression of mast cell-related leukocyte antigens was studied on isolated CMC as well as by in situ staining experiments. Corresponding results were obtained for most antigens. Thus, CMC express the MGF receptor c-kit (CD1 17), the surface receptor for IgE, and the mast cell-related enzymes tryptase and chymase. CMC also express the pan leukocyte antigen (CD45), the ICAM-1 antigen (CD54), the Pgp-l homing receptor (CD44), the myeloid marker gp67 (CD33), and leukosialin (CD43). The CD33 and CD43 antigens could only be detected by in situ staining experiments. This is consistent with the observed effect of pronase-E on expression of these antigens. Basophil-related leukocyte markers including LFA-1 alpha chain (CDlla), C3biR alpha chain (CDllb), and lactosylceramide (CDwl7) are not expressed on CMC. CMC also lack the lymphocyte marker antigens CD3 (TR), CD4 (class I1 receptor), and CD19 (B-cell marker), as well as the monocyte-related antigen CD14 (LPS SPERR ET AL R-related antigen). Thus, CMC express an almost identical cell surface membrane phenotype as compared with lung, skin, and uterus These findings support the concept that MC derived from various organs represent a homogeneous cell lineage in terms of surface marker expression. Two subtypes of human MC have been defined according to differential expression of proteolytic MC,, contain both tryptase and chymase, whereas MCT contain only tryptase but lack chymase. MCTc typically are located in human skin. Interestingly, in the present study, almost all CMC (90%) were found to be M&, as assessed by doubleimmunohistochemistry and analysis of serial sections. The MCTc phenotype was expressed in the epicardium, myocardium, and endocardium of the auricular appendages. However, CMC were obtained from CMP patients and thus from pathologic tissues. Whether the majority of CMC in normal heart also are MCTc remains to be determined.
The functional properties of the isolated CMC show many similarities to the well-characterized human lung and uterus MC. Like all other MC types, CMC released histamine in response to cross linkage of IgE binding sites. Furthermore, the mast cell agonist SCF (c-kit ligand) was able to induce dose-dependent release of histamine from isolated CMC and enhanced IgE-dependent releasability of CMC, as has been described for lung and uterus SP, a skin mast cell a g~n i s t ,~~.~~ failed to induce histamine liberation from CMC. Thus, although CMC are MCTc, they do not share all functional properties with skin MC. The basophil agonist FMLP did not show any effect on CMC.
The biologic role of CMC and the reason for the relatively high numbers of MC in the auricular appendages as opposed to other heart regions remain unknown. Recent observations point to potential endocrine functions of CMC in the atrial tissue. For example, MC-tryptase has been implicated in the degradation of the precursor of atrial natriuretic factor (pre-ANF) to its active molecular form, ANF?2 Other studies have shown that MC and mast cell enzymes are involved in the regulation of the angiotensidangiotensin converting enzyme (ACE) system43 and the processing of endothelin.M Moreover, MC have been implicated in the regulation of c~agulation~'.~ and in the modulation of endothelial cell function^.^"^^ These observations point to a possible role of CMC in local microenvironmental and vascular events. Interestingly, an increase in the number of CMC has been observed in graft rejection associated with tissue fibrosis For personal use only. on November 11, 2017. by guest www.bloodjournal.org From after heart transplantationp' as well as in auricular thrombos~s .~' An increase and accumulation of CMC has also been described in myocardial dysfunction and angiogenesis in experimental animal In summary, we have characterized human MC present in cardiac tissue. The CMC, an MCTc, is primarily located in the appendage of the atrium and exhibits functional and surface membrane antigen properties similar to those of lung and uterus MC. Studies are underway to clarify the physiologic and pathophysiologic role(s) of these CMC.
